These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 227603)

  • 1. Antigenic variation in visna virus.
    Scott JV; Stowring L; Haase AT; Narayan O; Vigne R
    Cell; 1979 Oct; 18(2):321-7. PubMed ID: 227603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographical rearrangements of visna virus envelope glycoprotein during antigenic drift.
    Stanley J; Bhaduri LM; Narayan O; Clements JE
    J Virol; 1987 Apr; 61(4):1019-28. PubMed ID: 2434662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precursor polypeptides to structural proteins of visna virus.
    Vigne R; Filippi P; Quérat G; Sauze N; Vitu C; Russo P; Delori P
    J Virol; 1982 Jun; 42(3):1046-56. PubMed ID: 6178845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant gp135 to study epitope-specific antibody responses to maedi visna virus.
    Carey N; Roy DJ; Dalziel RG
    J Virol Methods; 1993 Jul; 43(2):221-32. PubMed ID: 7690044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing and fusion-blocking antibodies induced by recombinant visna virus envelope glycoprotein.
    Huso DL
    Viral Immunol; 1997; 10(1):15-20. PubMed ID: 9095528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic changes associated with antigenic variation of visna virus durig persistent infection.
    Clements JE; Pedersen FS; Narayan O; Haseltine WA
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4454-8. PubMed ID: 6254026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of antigenic variants in maedi-visna virus infection.
    Andrésdóttir V; Skraban R; Matthíasdóttir S; Lutley R; Agnarsdóttir G; Thorsteinsdóttir H
    J Gen Virol; 2002 Oct; 83(Pt 10):2543-2551. PubMed ID: 12237438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic shift of visna virus in persistently infected sheep.
    Narayan O; Griffin DE; Chase J
    Science; 1977 Jul; 197(4301):376-8. PubMed ID: 195339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo.
    Thormar H; Barshatzky MR; Arnesen K; Kozlowski PB
    J Gen Virol; 1983 Jul; 64 (Pt 7)():1427-32. PubMed ID: 6306144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maedi-visna virus persistence: Antigenic variation and latency.
    Arnarson H; Pálsson A; Gudnadóttir M; Andrésdóttir V
    Comp Immunol Microbiol Infect Dis; 2017 Dec; 55():6-12. PubMed ID: 29127994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep.
    Narayan O; Griffin DE; Clements JE
    J Gen Virol; 1978 Nov; 41(2):343-52. PubMed ID: 214521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.
    Narayan O; Clements JE; Griffin DE; Wolinsky JS
    Infect Immun; 1981 Jun; 32(3):1045-50. PubMed ID: 6166562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for recombination in the envelope gene of maedi-visna virus.
    Andrésdóttir V
    Virus Genes; 2003 Aug; 27(1):5-9. PubMed ID: 12913353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblot analysis of the antibody response to ovine lentivirus infections.
    Houwers DJ; Nauta IM
    Vet Microbiol; 1989 Feb; 19(2):127-39. PubMed ID: 2539693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep.
    Lutley R; Pétursson G; Pálsson PA; Georgsson G; Klein J; Nathanson N
    J Gen Virol; 1983 Jul; 64 (Pt 7)():1433-40. PubMed ID: 6306145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.
    Skraban R; Matthíasdóttir S; Torsteinsdóttir S; Agnarsdóttir G; Gudmundsson B; Georgsson G; Meloen RH; Andrésson OS; Staskus KA; Thormar H; Andrésdóttir V
    J Virol; 1999 Oct; 73(10):8064-72. PubMed ID: 10482555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of visna-maedi virus antibodies and antigens by immunoblotting].
    Bosgiraud C; Rucheton M; Coste J; Lemaire JM; Nicolas JA; Simeon de Buochberg M; Beaubatie L
    Ann Rech Vet; 1989; 20(2):187-93. PubMed ID: 2546479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies against glycoprotein of Maedi-Visna virus released as soluble antigen in cell cultures.
    Bruns M; Straub OC; Weiland F; Feiler S
    Zentralbl Veterinarmed B; 1979 Aug; 26(6):461-8. PubMed ID: 232343
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune response to individual maedi-visna virus gag antigens.
    Singh I; McConnell I; Blacklaws B
    J Virol; 2006 Jan; 80(2):912-9. PubMed ID: 16378993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of a principal neutralization domain of visna/maedi virus envelope glycoprotein.
    Haflidadóttir BS; Matthíasdóttir S; Agnarsdóttir G; Torsteinsdóttir S; Pétursson G; Andrésson ÓS; Andrésdóttir V
    J Gen Virol; 2008 Mar; 89(Pt 3):716-721. PubMed ID: 18272763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.